Latest Biotech News

Bristol Myers Squibb’s Zenbexus, recently granted FDA accelerated approval for multiple myeloma, showed a 51% reduction in the risk of disease progression versus standard therapy in a Phase 3...

Roche is moving beyond licensing in China, striking a discovery collaboration with Defand Therapeutics focused on molecular glue medicines. Defand will discover and develop multiple candidates for...

Roche and other companies’ increasing reliance on digital and AI systems is colliding with stricter oversight and governance requirements. The European Medicines Agency said it will need to...

Caribou Biosciences is shutting down remaining clinical development plans for two allogeneic CAR-T programs after failing to secure financing for its late-stage trial plans, according to company...

Precision oncology diagnostics and pipeline readouts moved in tandem. A nanoparticle-enabled blood proteomics test can measure tumor hypoxia in bladder cancer, track it during radiotherapy, and...

Diabetes and metabolic care expanded with both repurposing and new mechanism work. A clinical study linked SGLT2 inhibitor therapy with lower circulating activin A levels and improved right-heart...

Cerevance announced Phase 3 success for solengepras in Parkinson’s disease, reporting reduced daily “off” time alongside improvements across other symptoms. The privately held company said it will...

TB screening accuracy is a central theme in infectious disease surveillance. A South African study found standard symptom screening detected about 22% of tuberculosis cases in people with...

Mechanism-driven cancer and immunology work emphasized new targets. A study in Nature Communications reported that inhibiting EP300 can restore antibacterial function in scar-associated...

Multiply Labs raised $75 million to scale robotic drug manufacturing toward commercial-scale workflows. The company focuses on automating midstream logistics between existing cell therapy...

Roche has struck a collaboration with Chinese startup Defand Therapeutics to discover and develop molecular glue medicines for cancer and immune-driven diseases, signaling a shift from licensing...

Genentech has signed an exclusive global licensing and development deal with Alector for AL050, a preclinical enzyme replacement therapy aimed at glucocerebrosidase deficiency in Parkinson’s...

Argenx reported an unfavorable Phase 3 result for Vyvgart in Sjögren’s disease, saying the treatment did not outperform placebo on primary endpoints. The announcement adds pressure to a pipeline...

A Dutch court ordered Merck to stop manufacturing and selling its subcutaneous formulation of Keytruda in eight European countries, ruling that Merck infringed a Halozyme patent. The decision...

Caribou Biosciences is stopping work on its remaining allogeneic CAR-T programs after failing to secure financing for a late-stage trial in lymphoma. The company said it will pursue strategic...

The European Medicines Agency said the EU Clinical Trials Information System will require major redevelopment to align with the proposed EU Biotech Act. The EMA said the planned changes would...

PhRMA sued the Trump administration over the Medicare GLOBE pilot, arguing the most-favored nation framework exceeds Medicare’s statutory authority for Part B drug pricing. PhRMA said the program...

Cerevance said its experimental oral Parkinson’s therapy solengepras reduced patients’ daily off-time in a Phase 3 trial, alongside other symptom improvements. The company plans to discuss a...

Matchpoint Therapeutics, a biotech partnered with Novartis, raised $150 million in a Series B round to advance its lead program toward clinical testing. The financing underscores continued...

Multiply Labs raised $75 million to expand robotic manufacturing systems designed to integrate between existing cell therapy production instruments. The company said its approach targets...